Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.

Jin, Xuanyou; Kim, Eunwoo; Huh, Ki Young; Hwang, Inyoung; Cho, Joo-Youn; Yu, Kyung-Sang; Lee, SeungHwan

Jin, Xuanyou; Kim, Eunwoo; Huh, Ki Young; Hwang, Inyoung; Cho, Joo-Youn; Yu, Kyung-Sang; Lee, SeungHwan.

Afiliação

Jin X; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Kim E; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Huh KY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Cho JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.

Transl Clin Pharmacol ; 28(1): 43-54, 2020 Mar.

Article em En | MEDLINE | ID: mdl-32274380

Palavras-chave

Fixed-dose combination; Gemigliptin; Metformin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google